The grant will fund development work that will focus on the efficacy of a genetically modified living human skin substitute called ExpressGraftEnhance tissue in the prevention and disruption of biofilms. A biofilm is a community of bacteria growing in a matrix that adheres to a surface.
A recent sconcludes that the prevalence of children being served under the special education autism category in Wisconsin seems to be leveling off in the school districts with the highest prevalence rates.
As researchers delve further into the genetic basis for disease, they face a conundrum: finding enough affected people who can fill out a true picture of mutations that can vary from one person to another.
It comes as no surprise that many children suffer when a parent is behind bars. But as rates of incarceration grew over the past 30 years, researchers were slow to focus on the collateral damage to children.
The parents of grown children with autism are more likely to divorce than couples with typically developing children, according to new data from a large longitudinal study of families of adolescents and adults with autism.
An article in the Milwaukee Journal Sentinal Online featured findings published in a recent paper by Maureen Durkin, PhD, DrPH, titled “Socioeconomic Inequality in the Prevalence of Autism Spectrum Disorder: Evidence from a U.S. Cross-Sectional Study.“
Using novel screens to sort through libraries of drugs already approved for use in human patients, a team of Wisconsin researchers has identified several compounds that could be used to treat a rare and deadly neurological disorder.
by Terry Devitt University Communications With more than 100 billion neurons and billions of other specialized cells, the human brain is a marvel of nature. It is the organ that makes people unique. Now, writing …
Intriguingly, the new study suggests the presence or absence of the genes used to reprogram skin cells to become the blank slate pluripotent cells makes no difference in terms of their capacity to differentiate.
The long struggle to move the most versatile stem cells from the laboratory to the clinic got another boost with an $8.8 million contract award to the Waisman Clinical Biomanufacturing Facility at the University of Wisconsin-Madison.